EVIDENCE OF NON-DEFICIENT LOW-DENSITY-LIPOPROTEIN RECEPTOR PATIENTS IN A POOL OF SUBJECTS WITH CLINICAL FAMILIAL HYPERCHOLESTEROLEMIA PROFILE

被引:16
作者
LESTAVELDELATTRE, S
BENHAMAMOUCH, S
AGNANI, G
LUC, G
BARD, JM
BROUSSEAU, T
BILLARDON, C
KUSNIERZ, JP
DEGENNES, JL
FRUCHART, JC
CLAVEY, V
机构
[1] INST PASTEUR, SERLIA, INSERM, U325, F-59019 LILLE, FRANCE
[2] INST PASTEUR, CNRS 624, INSERM, U167, F-59019 LILLE, FRANCE
[3] FAC PHARM LILLE, LILLE, FRANCE
[4] HOP PITIE, INSERM, U321, F-75651 PARIS, FRANCE
[5] HOP LA PITIE SALPETRIERE, SERV ENDOCRINOL, PARIS, FRANCE
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1994年 / 43卷 / 04期
关键词
D O I
10.1016/0026-0495(94)90066-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For this study, we selected 41 adult patients with the classic clinical diagnosis of heterozygous familial hypercholesterolemia (FH), which is characterized by a low-density lipoprotein (LDL) cholesterol level above the 95th percentile, xanthomas, and/or personal or familial cardiovascular history. We used an indirect immunocytofluorimetric assay to classify these 41 subjects according to LDL receptor function on lymphocytes. We found that LDL receptor activity was normal in nine patients. A large study of plasma lipid, lipoprotein, and apolipoprotein levels found no significant difference between patients with and without LDL receptor defect. Familial defective apolipoprotein (apo) B-100 (FDB) and LDL-binding defects were not found in the nine patients without LDL receptor defect. These results suggest that other defects in the regulation of lipoprotein metabolism are capable of giving rise to a clinical and biochemical disorder indistinguishable from classic FH. © 1994.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 32 条
[1]  
BARD JM, 1988, ATHEROSCLER REV, V18, P153
[2]  
BENHAMAMOUCH S, 1988, BIOCHIM BIOPHYS ACTA, V1002, P45
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]  
BROUSSEAU T, 1993, CLIN CHEM, V39, P960
[5]  
Brown M S, 1975, Adv Intern Med, V20, P273
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]  
FRUCHART JC, 1985, METHOD ENZYMAT AN, P126
[8]  
Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215
[9]   THE LDL RECEPTOR DEFECT IN FAMILIAL HYPERCHOLESTEROLEMIA - IMPLICATIONS FOR PATHOGENESIS AND THERAPY [J].
GOLDSTEIN, JL ;
BROWN, MS .
MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (02) :335-362
[10]  
GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153